The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is a member of the nuclear receptor superfamily of ligand-dependent transcription factors that is predominantly expressed in adipose tissue, adrenal gland and spleen. PPAR-gamma has been demonstrated to regulate adipocyte differentiation and glucose homeostasis in response to several structurally distinct compounds, including thiazolidinediones and fibrates. Naturally occurring compounds such as fatty acids and the prostaglandin D2 metabolite 15-deoxy-delta prostaglandin J2 (15d-PGJ2) bind to PPAR-gamma and stimulate transcription of target genes. Prostaglandin D2 metabolites have not yet been identified in adipose tissue, but are major products of arachidonic-acid metabolism in macrophages, raising the possibility that they might serve as endogenous PPAR-gamma ligands in this cell type. Here we show that PPAR-gamma is markedly upregulated in activated macrophages and inhibits the expression of the inducible nitric oxide synthase, gelatinase B and scavenger receptor A genes in response to 15d-PGJ2 and synthetic PPAR-gamma ligands. PPAR-gamma inhibits gene expression in part by antagonizing the activities of the transcription factors AP-1, STAT and NF-kappaB. These observations suggest that PPAR-gamma and locally produced prostaglandin D2 metabolites are involved in the regulation of inflammatory responses, and raise the possibility that synthetic PPAR-gamma ligands may be of therapeutic value in human diseases such as atherosclerosis and rheumatoid arthritis in which activated macrophages exert pathogenic effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In microglia and macrophages, PPAR␥ activation inhibits proinflammatory gene expression (Jiang et al., 1998;Ricote et al., 1998).”
From PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice (2012) · cites this paper as Ricote et al., 1998
In the citing paper
“Moreover, inhibiting nuclear factor B (NFB) decreases expression of inflammatory cytokines such as interleukin (IL)-1, tumor necrosis factor ␣ (TNF␣) or IL-6 (12).”
From MicroRNA-27b Contributes to Lipopolysaccharide-mediated Peroxisome Proliferator-activated Receptor γ (PPARγ) mRNA Destabilization (2010) · cites this paper as [12]
In the citing paper
“PPAR␥ is well established for its anti-inflammatory effects in attenuating the production of pro-inflammatory mediators (12).”
From MicroRNA-27b Contributes to Lipopolysaccharide-mediated Peroxisome Proliferator-activated Receptor γ (PPARγ) mRNA Destabilization (2010) · cites this paper as [12]
In the citing paper
“Next to its role in HSCs, PPAR-γ is primarily expressed in macrophages and is capable to inhibit AP-1, STAT1 and NF-κB, therefore decreasing the inflammatory response.[136]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [136]
In the citing paper
“Next to its role in HSCs, PPAR-γ is primarily expressed in macrophages and is capable to inhibit AP-1, STAT1 and NF-κB, therefore decreasing the inflammatory response.[136]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [136]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90118-x · Cited by 12,077
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Self-citationStimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164
Self-citationKliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Self-citationKliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
The matrix‐degrading metalloproteinases
Matrisian, L. M. (1992) · BioEssays · doi:10.1002/bies.950140705 · Cited by 1,364
Krey, G. D., Braissant, O., L’Horset, F., Kalkhoven, E., Perroud, M., Parker, M. G., & Wahli, W. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.779 · Cited by 1,221
Cited by
Items 601–700 of 1,039
Dowell, P., Ishmael, J. E., Avram, D., Peterson, V. J., Nevrivy, D. J., & Leid, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15901 · Cited by 136
Gong, P., Stewart, D., Hu, B., Li, N., Cook, J., Nel, A., & Alam, J. (2002) · Antioxidants & Redox Signaling · doi:10.1089/152308602753666307 · Cited by 137
Multiple facets of macrophages in renal injury
Kluth, D., Erwig, L., & Rees, A. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00773.x · Cited by 145
Adiponectin reduces lipid accumulation in macrophage foam cells
Tian, L., Luo, N., Klein, R. L., Chung, B. H., Garvey, W. T., & Fu, Y. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.011 · Cited by 150
Nakamura, T., Suzuki, H., Wada, Y., Kodama, T., & Doi, T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.146 · Cited by 150
Llopis, J., Westin, S., Ricote, M., Wang, J., Cho, C. Y., Kurokawa, R., Mullen, T.-M., Rose, D. W., Rosenfeld, M. G., Tsien, R. Y., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4363 · Cited by 139
Self-citationGarg, R., Kumbkarni, Y., Aljada, A., Mohanty, P., Ghanim, H., Hamouda, W., & Dandona, P. (2000) · Hypertension · doi:10.1161/01.hyp.36.3.430 · Cited by 141
Chrysin attenuates inflammation by regulating M1/M2 status via activating PPARγ
Feng, X., Qin, H., Shi, Q., Zhang, Y., Zhou, F., Wu, H., Ding, S., Niu, Z., Lü, Y., & Shen, P. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.03.016 · Cited by 146
The nuclear receptor PPARγ-bigger than fat
Kliewer, S. A., & Willson, T. M. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80014-2 · Cited by 154
Self-citationSzabo, G., Velayudham, A., Romics, L., & Mandrekar, P. (2005) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000189287.83544.33 · Cited by 136
Carta, A. R., Frau, L., Pisanu, A., Wardas, J., Spiga, S., & Carboni, E. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.046 · Cited by 148
de Jong, M., van der Worp, H. B., van der Graaf, Y., Visseren, F. L. J., & Westerink, J. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0617-4 · Cited by 132
Effect of Supplementation With High-Selenium Yeast on Plasma Lipids
Rayman, M. P., Stranges, S., Griffin, B. A., Pastor‐Barriuso, R., & Güallar, E. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-10-201105170-00005 · Cited by 137
Kim, E. J., Kwon, K. J., Park, J.-Y., Lee, S., Moon, C., & Baik, E. J. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02480-0 · Cited by 146
Inducible nitric oxide synthase activation by interleukin-17
Miljković, D. M., & Trajković, V. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.10.003 · Cited by 138
Wan, Y. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.08.006 · Cited by 158
Inhibition of COX‐2 expression by endocannabinoid 2‐arachidonoylglycerol is mediated via PPAR‐γ
Du, H., Chen, X., Zhang, J., & Chen, C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01444.x · Cited by 134
Trivedi, S. G., Newson, J., Rajakariar, R., Jacques, T. S., Hannon, R., Kanaoka, Y., Eguchi, N., Colville‐Nash, P., & Gilroy, D. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507175103 · Cited by 150
Giri, S., Rattan, R., Singh, A. K., & Singh, I. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.5196 · Cited by 137
Macrophages and Diabetic Nephropathy
Tesch, G. H. (2010) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2010.03.007 · Cited by 137
PPAR‐gamma modulates allergic inflammation through up‐regulation of PTEN
Lee, K. S., Park, S. J., Hwang, P. H., Yi, H. K., Song, C. H., Chai, O. H., Kim, J., Lee, M. K., & Lee, Y. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-3309fje · Cited by 141
Zapata-Gonzalez, F., Rueda, F., Petriz, J., Domingo, P., Villarroya, F., Diaz-Delfin, J., de Madariaga, M. A., & Domingo, J. C. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1007688 · Cited by 132
PPARγ in Monocytes: Less Pain, Any Gain?
Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81567-6 · Cited by 147
Cutaneous Nociception Evoked by 15-delta PGJ2 via Activation of Ion Channel TRPA1
Cruz-Orengo, L., Dhaka, A., Heuermann, R. J., Young, T. J., Montana, M. C., Cavanaugh, E. J., Kim, D., & Story, G. M. (2008) · Molecular Pain · doi:10.1186/1744-8069-4-30 · Cited by 131
A crucial role for macrophages in the pathology of K/B × N serum‐induced arthritis
Solomon, S., Rajasekaran, N., Jeisy‐Walder, E., Snapper, S. B., & Illges, H. (2005) · European Journal of Immunology · doi:10.1002/eji.200526167 · Cited by 134
Bordji, K., Grillasca, J.-P., Gouze, J.-N., Magdalou, J., Schohn, H., Keller, J.-M., Bianchi, A., Dauça, M., Netter, P., & Terlain, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.12243 · Cited by 134
Yu, C., York, B., Wang, S., Feng, Q. F., Xu, J., & O’Malley, B. W. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.01.025 · Cited by 142
Mild Hypothermia Inhibits Nuclear Factor-κB Translocation in Experimental Stroke
Han, H. S., Karabiyikoglu, M., Kelly, S., Sobel, R. A., & Yenari, M. A. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000059566.39780.8d · Cited by 156
Núñez, V., Alameda, D., Rico, D., Mota, R., Gonzalo, P., Cedenilla, M., Fischer, T., Boscá, L., Glass, C. K., Arroyo, A. G., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913545107 · Cited by 133
Self-citationSurh, Y., Na, H., Park, J., Lee, H., Kim, W., Yoon, I., & Kim, D. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.100 · Cited by 152
Wang, J., Xia, J., Huang, R., Hu, Y., Fan, J., Shu, Q., & Xu, J. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01937-8 · Cited by 124
Sheppe, A. E. F., & Edelmann, M. J. (2021) · Infection and Immunity · doi:10.1128/iai.00095-21 · Cited by 144
Pleiotropic effects of thiazolidinediones: Taking a look beyond antidiabetic activity
Giannini, S., Serio, M., & Galli, A. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03347546 · Cited by 137
Takeda, K., Ichiki, T., Tokunou, T., Iino, N., & Takeshita, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108722200 · Cited by 133
Bonfield, T. L., Farver, C. F., Barna, B. P., Malur, A., Abraham, S., Raychaudhuri, B., Kavuru, M. S., & Thomassen, M. J. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0148oc · Cited by 131
Robinson, E., & Grieve, D. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.03.003 · Cited by 138
Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) and Neurodegenerative Disorders
Chen, Y., Wu, J., Tsai, H.-D., Huang, C., Chen, J.-J., Sun, G. Y., & Lin, T. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8259-8 · Cited by 144
New insights into the role of COX 2 in inflammation
Gilroy, D. W., & Colville‐Nash, P. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000094 · Cited by 144
Planagumà, A., Clària, J., Miquel, R., López‐Parra, M., Titos, E., Masferrer, J. L., Arroyo, V., & Rodé, J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2753fje · Cited by 133
Molecular Basis for the Direct Inhibition of AP-1 DNA Binding by 15-Deoxy-Δ12,14-prostaglandin J2
Pérez‐Sala, D., Cernuda‐Morollón, E., & Cañada, F. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309409200 · Cited by 147
Kintscher, U., Goetze, S., Wakino, S., Kim, S., Nagpal, S., Chandraratna, R. A. S., Graf, K., Fleck, E., Hsueh, W. A., & Law, R. E. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00461-1 · Cited by 146
Macrophage immunoregulatory pathways in tuberculosis
Rajaram, M. V. S., Ni, B., Dodd, C. E., & Schlesinger, L. S. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.09.010 · Cited by 126
Mastrofrancesco, A., Ottaviani, M., Aspite, N., Cardinali, G., Izzo, E., Graupe, K., Zouboulis, C. C., Camera, E., & Picardo, M. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2010.01107.x · Cited by 127
Peroxisome proliferator‐activated receptor‐γ: too much of a good thing causes harm
Cock, T., Houten, S. M., & Auwerx, J. (2004) · EMBO reports · doi:10.1038/sj.embor.7400082 · Cited by 131
Bishop‐Bailey, D., & Wray, J. A. (2003) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(03)00003-0 · Cited by 151
New insights into COX-2 biology and inhibition
Patrignani, P., Tacconelli, S., Sciulli, M. G., & Capone, M. L. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.024 · Cited by 146
Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation
Belvisi, M. G., Hele, D. J., & Birrell, M. A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.048 · Cited by 141
Peroxisome proliferator-activated receptor γ in malignant diseases
WANG, T., Xu, J., Yu, X., Yang, R., & Han, Z. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.08.011 · Cited by 151
Profiling of promoter occupancy by PPARα in human hepatoma cells via ChIP-chip analysis
van der Meer, D. L. M., Degenhardt, T., Väisänen, S., de Groot, P. J., Heinäniemi, M., de Vries, S. C., Müller, M., Carlberg, C., & Kersten, S. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq012 · Cited by 128
Díaz-Guerra, M. J. M., Castrillo, A., Martín-Sanz, P., & Boscá, L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.6184 · Cited by 130
Liu, J., Li, H., Burstein, S. H., Zurier, R. B., & Chen, J. D. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.983 · Cited by 129
Barbier, O., Villeneuve, L., Bocher, V., Fontaine, C., Torra, I. P., Duhem, C., Kosykh, V., Fruchart, J.-C., Guillemette, C., & Staels, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300749200 · Cited by 128
Peroxisome Proliferator-Activated Receptor γ: Implications for Cardiovascular Disease
Hsueh, W. A., & Bruemmer, D. (2004) · Hypertension · doi:10.1161/01.hyp.0000113626.76571.5b · Cited by 137
Troglitazone and liver injury: In search of answers†
Chojkier, M. (2005) · Hepatology · doi:10.1002/hep.20567 · Cited by 125
Macrophage Polarization and Insulin Resistance: PPARγ in Control
Charo, I. F. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.07.006 · Cited by 147
PPARs and other nuclear receptors in inflammation
RIZZO, G., & Fiorucci, S. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.03.012 · Cited by 139
Synergy between PPARγ Ligands and Platinum-Based Drugs in Cancer
Girnun, G. D., Naseri, E., Vafai, S. B., Qu, L., Szwaya, J. D., Bronson, R. T., Alberta, J. A., & Spiegelman, B. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.025 · Cited by 128
Libby, P., & Plutzky, J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.004 · Cited by 138
Takata, Y., Kitami, Y., Yang, Z.-H., Nakamura, M., Okura, T., & Hiwada, K. (2002) · Circulation Research · doi:10.1161/01.res.0000031271.20771.4f · Cited by 130
Activation of Peripheral Blood CD14+ Monocytes Occurs in Diabetes
Cipolletta, C., Ryan, K. E., Hanna, E. V., & Trimble, E. R. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2779 · Cited by 128
Peters, J. M., Rusyn, I., Rose, M. L., Gonzalez, F. J., & Thurman, R. G. (2000) · Carcinogenesis · doi:10.1093/carcin/21.4.823 · Cited by 129
Gene Expression Changes Induced by PPAR Gamma Agonists in Animal and Human Liver
Rogue, A., Spire, C., Brun, M., Claude, N., & Guillouzo, A. (2010) · PPAR Research · doi:10.1155/2010/325183 · Cited by 121
Garrido-Gil, P., Joglar, B., Rodriguez-Perez, A. I., Guerra, M. J., & Labandeira-Garcia, J. L. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-38 · Cited by 127
Ghosh, A. K., Bhattacharyya, S., Wei, J., Kim, S., Barak, Y., Mori, Y., & Varga, J. (2009) · The FASEB Journal · doi:10.1096/fj.08-128736 · Cited by 133
The Role and Regulation of the Nuclear Factor Kappa B Signalling Pathway in Human Labour
Lappas, M., & Rice, G. E. (2006) · Placenta · doi:10.1016/j.placenta.2006.05.011 · Cited by 138
Kornman, K. S. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.475s · Cited by 139
Peroxisome proliferator-activated receptor γ C161→T polymorphism and coronary artery disease
Wang, X., Oosterhof, J., & Duarte, N. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00256-4 · Cited by 136
15d-Prostaglandin J 2 Protects Brain From Ischemia-Reperfusion Injury
Lin, T.-N., Cheung, W.-M., Wu, J.-S., Chen, J.-J., Lin, H., Chen, J.-J., Liou, J.-Y., Shyue, S.-K., & Wu, K. K. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000201933.53964.5b · Cited by 129
Lebovic, D. I., Kir, M., & Casey, C. L. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.02.148 · Cited by 130
Expression and Function of Peroxisome Proliferator–Activated Receptor-γ in Mesangial Cells
Nicholas, S. B., Kawano, Y., Wakino, S., Collins, A. R., & Hsueh, W. A. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.722 · Cited by 132
Fang, F., Kang, Z., & Wong, C. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900119 · Cited by 133
The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders
del Río, C., Millán, E., García, V., Appendino, G., DeMesa, J., & Muñóz, E. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.022 · Cited by 138
Anti-NASH Drug Development Hitches a Lift on PPAR Agonism
Boeckmans, J., Natale, A., Rombaut, M., Buyl, K., Rogiers, V., De Kock, J., Vanhaecke, T., & Rodrigues, R. M. (2019) · Cells · doi:10.3390/cells9010037 · Cited by 122
Lee, J. W., Bajwa, P. J., Carson, M. J., Jeske, D. R., Cong, Y., Elson, C. O., Lytle, C. Y., & Straus, D. S. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.113 · Cited by 135
Peroxisome Proliferator–Activated Receptor- γ Regulates Airway Epithelial Cell Activation
Wang, A. C. C., Dai, X., Luu, B., & Conrad, D. J. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.6.4376 · Cited by 127
Calkin, A. C., Forbes, J. M., Smith, C. M., Lassila, M., Cooper, M. E., Jandeleit-Dahm, K. A., & Allen, T. J. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000177813.99577.6b · Cited by 128
12/15-Lipoxygenase, Oxidative Modification of LDL and Atherogenesis
Cyrus, C. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00096-2 · Cited by 139
Molecular mechanism of PPAR in the regulation of age-related inflammation
Chung, J. H., Seo, A. Y., Chung, S. W., Kim, M. K., Leeuwenburgh, C., Yu, B. P., & Chung, H. Y. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2008.01.001 · Cited by 132
Alleva, D. G., Johnson, E. B., Lio, F. M., Boehme, S. A., Conlon, P. J., & Crowe, P. D. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.677 · Cited by 105
Setoguchi, K., Misaki, Y., Terauchi, Y., Yamauchi, T., Kawahata, K., Kadowaki, T., & Yamamoto, K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13202 · Cited by 127
Feng, S., Reuss, L. E., & Wang, Y. (2016) · Molecules · doi:10.3390/molecules21101278 · Cited by 139
Quinn, L. P., Crook, B., Hows, M. E., Vidgeon‐Hart, M., Chapman, H., Upton, N., Medhurst, A. D., & Virley, D. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.78 · Cited by 118
Villapol, S., Yaszemski, A. K., Logan, T. T., Sánchez-Lemus, E., Saavedra, J. M., & Symes, A. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.152 · Cited by 125
Oxidative Stress in the Thyroid Gland: From Harmlessness to Hazard Depending on the Iodine Content
Poncin, S., Gérard, A.-C., Boucquey, M., Sènou, M., Calderón, P. B., Knoops, B., Lengelé, B., Many, M., & Colin, I. M. (2007) · Endocrinology · doi:10.1210/en.2007-0951 · Cited by 128
Cuzzocrea, S., Wayman, N. S., Mazzon, E., Dugo, L., Di Paola, R., Serraino, I., Britti, D., Chatterjee, P. K., Caputi, A. P., & Thiemermann, C. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.5.997 · Cited by 122
Bassaganya-Riera, J., Hontecillas-Magarzo, R., Bregendahl, K., Wannemuehler, M. J., & Zimmerman, D. R. (2001) · Journal of Animal Science · doi:10.2527/2001.793714x · Cited by 124
Large Scale Gene Expression Analysis of Cholesterol-loaded Macrophages
Shiffman, D., Mikita, T., Tai, J., Wade, D. P., Porter, J. G., Seilhamer, J. J., Somogyi, R., Liang, S., & Lawn, R. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004732200 · Cited by 133
Bassaganya-Riera, J., Guri, A. J., Lu, P., Climent, M., Carbo, A., Sobral, B., Horne, W. T., Lewis, S. N., Bevan, D. R., & Hontecillas, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.160077 · Cited by 124
PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation
Zolezzi, J. M., Santos, M. J., Bastías‐Candia, S., Pinto, C., Godoy, J. A., & Inestrosa, N. C. (2017) · Biological Reviews · doi:10.1111/brv.12320 · Cited by 122
Tokutome, M., Matoba, T., Nakano, Y., Okahara, A., Fujiwara, M., Koga, J., Nakano, K., Tsutsui, H., & Egashira, K. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy200 · Cited by 125
Klotz, L., Dani, I., Edenhofer, F., Nolden, L., Evert, B., Paul, B., Kolanus, W., Klockgether, T., Knolle, P., & Diehl, L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2122 · Cited by 122
Atorvastatin activates PPAR-γ and attenuates the inflammatory response in human monocytes
Grip, O., Janciauskiene, S. M., & Lindgren, S. C. (2002) · Inflammation Research · doi:10.1007/bf02684000 · Cited by 140
Guo, B., Koya, D., Isono, M., Sugimoto, T., Kashiwagi, A., & Haneda, M. (2004) · Diabetes · doi:10.2337/diabetes.53.1.200 · Cited by 128
PPAR and Immune System-What Do We Know?
Zhang, X., & Young, H. A. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00057-7 · Cited by 123
Palma, A., Jarrah, A. S., Tieri, P., Cesareni, G., & Castiglione, F. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01659 · Cited by 122
Zhao, X., Gonzales, N., & Aronowski, J. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12350 · Cited by 120
Yun, S., Kim, S., & Kim, E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00162 · Cited by 130
Fuentes, L., Rőszer, T., & Ricote, M. (2010) · Mediators of Inflammation · doi:10.1155/2010/219583 · Cited by 119
Self-citationNitric oxide synthase 2 and cyclooxygenase 2 interactions in inflammation
Weinberg, J. B. (2000) · Immunologic Research · doi:10.1385/ir:22:2-3:319 · Cited by 121
Praticò, D., & Trojanowski, J. Q. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00141-x · Cited by 116
Metadata
- Authors
- Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K.
- Affiliations
- United States Department of Veterans Affairs (US)
- Veterans Health Administration (US)
- University of California San Diego (US)
- Corresponding author
- Glass, Christopher K.
- Venue
- Nature
- Published
- 1998-01
- Volume
- 391
- Issue
- 6662
- Pages
- 79-82
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1633340712
- Cited by
- 3,525
- References
- 27
- Citations by year
- 2026: 30 · 2025: 41 · 2024: 34 · 2023: 44 · 2022: 59 · 2021: 84 · 2020: 73 · 2019: 65 · 2018: 89 · 2017: 82 · 2016: 86 · 2015: 95 · 2014: 113 · 2013: 106 · 2012: 137
- FWCI
- 53.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- PPARγ, macrophage activation, prostaglandin D2 metabolites, inducible nitric oxide synthase, MMP-9, scavenger receptor A, AP-1, STAT, NF-κB, transcriptional regulation, inflammation, atherosclerosis, rheumatoid arthritis, PPARγ ligands
- MeSH terms
- Bone Marrow Cells, Gene Expression Regulation, HeLa Cells, Humans, Macrophage Activation, Macrophages, Promoter Regions, Genetic, Transcription Factors, Tumor Cells, Cultured, Prostaglandin D2, Collagenases, Macrophages, Peritoneal, Receptors, Cytoplasmic and Nuclear, Inflammation Mediators, Nitric Oxide Synthase, Matrix Metalloproteinase 9
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.